Experience
Roche Diagnostics Corp.
Home Diagnostics Inc. (HDI)
Home Diagnostics Inc. (now Nipro Diagnostics) is one of the largest cobranders of blood glucose products for diabetics and offers low-cost alternatives to products offered by competitors. After a three-year battle with Roche, the district court granted a summary judgment of noninfringement in favor of HDI, concluding that no reasonable juror could find that HDI products infringed Roche's patent relating to blood glucose monitors. The first phase of the case had concluded successfully for HDI when the court ruled, following a bench trial, that Roche's other patent-in-suit had been obtained by inequitable conduct and is unenforceable.
Roche Diagnostics Corp. v. Home Diagnostics Inc. (HDI), 1:04-cv-00358, S.D. Ind., Judges McKinney, Shields
Mobileye, Inc.
Eli Lilly and Co. v. Apotex Inc.
Eli Lilly and Company
Closure Systems International v. Novembal USA, Inc.
Novembal USA, Inc.
Kitt Holdings, Inc. v. Mobileye BV
Mobileye BV
Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.
Eli Lilly and Company
Home Diagnostics, Inc. v. LifeScan, Inc.
Home Diagnostics, Inc.
Sud-Chemie AG v. CSP Technologies, Inc.
Sud-Chemie Incorporated
ArjoHuntleigh
Firestone Industrial Products v. Morrow
Firestone Industrial Products
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.